Halia Therapeutics

Halia Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company headquartered in Lehi, Utah, founded in 2017 and led by CEO Dr. David Bearss. Halia discovers and develops small-molecule therapies that target the immune system's inflammatory response — chiefly allosteric NEK7/NLRP3 inflammasome inhibition and LRRK2 inhibition — to resolve the chronic inflammation that drives hematologic, metabolic and neurodegenerative disease. Its lead clinical program, ofirnoflast (HT-6184), holds FDA Fast Track and Orphan Drug designation for lower-risk myelodysplastic syndromes; HT-4253, an LRRK2 inhibitor aimed at neuroinflammation and Alzheimer's prevention in APOE4 carriers, has completed a first-in-human Phase 1 study. The company also markets a "genetic resilience" research platform (GENMOR) built on family-cohort genomics. Halia is a drug developer, not a software vendor: it publishes a Webflow corporate site with pipeline, platform and press pages, and no developer program, public API, SDK or machine-readable specification of any kind.

Halia Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Drug Discovery.

Halia Therapeutics’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0

0 APIs

Company Biotechnology Pharmaceuticals Life Sciences Drug Discovery Clinical Trials Immunology Neuroscience Genomics Health

Kin Score

Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0

Composite quality — 7.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.2 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/halia-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

About

About

Blog

Blog

Source (apis.yml)

aid: halia-therapeutics
name: Halia Therapeutics
description: 'Halia Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company headquartered in Lehi,
  Utah, founded in 2017 and led by CEO Dr. David Bearss. Halia discovers and develops small-molecule therapies that target
  the immune system''s inflammatory response — chiefly allosteric NEK7/NLRP3 inflammasome inhibition and LRRK2 inhibition
  — to resolve the chronic inflammation that drives hematologic, metabolic and neurodegenerative disease. Its lead clinical
  program, ofirnoflast (HT-6184), holds FDA Fast Track and Orphan Drug designation for lower-risk myelodysplastic syndromes;
  HT-4253, an LRRK2 inhibitor aimed at neuroinflammation and Alzheimer''s prevention in APOE4 carriers, has completed a first-in-human
  Phase 1 study. The company also markets a "genetic resilience" research platform (GENMOR) built on family-cohort genomics.
  Halia is a drug developer, not a software vendor: it publishes a Webflow corporate site with pipeline, platform and press
  pages, and no developer program, public API, SDK or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/halia-therapeutics/refs/heads/main/apis.yml
image: https://cdn.prod.website-files.com/688b451b45ceaa63f2f18f66/688cae0819292502275bf280_Company%20Logo.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Clinical Trials
- Immunology
- Neuroscience
- Genomics
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://haliatx.com/
- type: About
  url: https://haliatx.com/about
- type: Blog
  url: https://haliatx.com/news
- type: Support
  url: https://haliatx.com/contact
- type: PrivacyPolicy
  url: https://haliatx.com/privacy-policy
- type: DomainSecurity
  url: security/halia-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Halia Therapeutics is a clinical-stage biopharmaceutical developer whose only public web property is a Webflow marketing
    site; every OpenAPI/GraphQL/MCP/A2A discovery path on haliatx.com returns a 404 HTML page, no api/dev/docs/portal subdomain
    resolves in DNS, and no GitHub organization exists under haliatx or halia-therapeutics.
  evidence:
  - url: https://haliatx.com/openapi.json
    status: 404
  - url: https://haliatx.com/.well-known/api-catalog
    status: 404
  - url: https://haliatx.com/.well-known/agent-card.json
    status: 404
  - url: https://api.github.com/orgs/haliatx
    status: 404
  - url: https://haliatx.com/
    status: 200
  checked: '2026-08-22'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/halia-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/halia-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/halia-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.